Cognition Therapeutics Inc (CGTX): Depreciation & Amortization
$36.0K
Year ended 2025-12-31
-24.3%
3-year compound annual growth
-18.2%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $36.0K | -66.4% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $107.0K | +11.5% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $96.0K | +15.7% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $83.0K | -10.8% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | $93.0K | -5.1% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $98.0K | n/a | 2022-03-30, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Cognition Therapeutics Inc (CGTX) | 2025-12-31 | $36.0K | -66.4% |
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | $3.96M | -22.4% |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $364.0K | -9.9% |
| Passage BIO, Inc. (PASG) | 2025-12-31 | $728.0K | -76.4% |
| Elutia Inc. (ELUT) | 2025-12-31 | $2.79M | -19.3% |
| Jasper Therapeutics, Inc. (JSPR) | 2025-12-31 | $1.06M | -23.1% |
| Armata Pharmaceuticals, Inc. (ARMP) | 2024-12-31 | $1.32M | +36.3% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $58.6K | -27.9% |
| CEL SCI Corp (CVM) | 2025-09-30 | $3.89M | -2.1% |
Compare CGTX, SGMOQ, CRDF, PASG side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗